ImmunoVec develops in vivo therapies designed to precisely engineer specific cell types within the human body. The company utilizes proprietary cell type-specific transcriptional control elements that regulate the expression of any DNA-encodable payload. These expression cassettes are compatible with both viral and non-viral delivery platforms to ensure precise targeting.
Funding
$4.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Terminal genetic diseases of the immune system currently lack effective curative treatments, leaving patients with limited options and significantly reduced quality of life. Existing therapies often manage symptoms but do not address the underlying genetic cause of the disease.
Solution
immunoVec is developing gene therapy treatments designed to cure these terminal genetic diseases by directly targeting and correcting the underlying genetic defects within the immune system. Their approach utilizes advanced gene editing techniques to restore healthy immune function at the cellular level. By correcting the genetic errors, immunoVec aims to provide a one-time, curative treatment that eliminates the need for chronic symptom management and enables patients to achieve lasting health improvements. This approach offers the potential for a significant improvement in the quality of life for individuals suffering from these debilitating conditions.
Target Audience
The primary target audience includes patients diagnosed with terminal genetic diseases of the immune system and their families, as well as hematologists and other specialists involved in the treatment of these conditions.
Features
- Gene therapy treatments targeting specific genetic mutations in immune cells.
- Advanced gene editing techniques for precise correction of genetic defects.
- Focus on restoring healthy immune function at the cellular level.
- Potential for a one-time curative treatment.